We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+18.68%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.69B
AUM Growth
+$682M
Cap. Flow
-$395M
Cap. Flow %
-5.9%
Top 10 Hldgs %
54.02%
Holding
678
New
246
Increased
85
Reduced
72
Closed
235

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$85.8M
2
INDV icon
Indivior Pharmaceuticals
INDV
+$59.6M
3
BCAX
Bicara Therapeutics
BCAX
+$45.8M
4
MRUS
Merus
MRUS
+$34.4M
5
VTRS icon
Viatris
VTRS
+$30M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$102M
2
SGRY icon
Surgery Partners
SGRY
+$86.4M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$53.7M
4
IART icon
Integra LifeSciences
IART
+$42.8M
5
BNTX icon
BioNTech
BNTX
+$38.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Industrials 0.73%
3 Technology 0.55%
4 Financials 0.45%
5 Consumer Discretionary 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
501
DELISTED
Esperion Therapeutics
ESPR
– –
-66,588
Closed -$148K
ET icon
502
Energy Transfer Partners
ET
$69.5B
– –
-26,024
Closed -$422K
EXEL icon
503
Exelixis
EXEL
$13.9B
– –
-20,816
Closed -$468K
EXPO icon
504
Exponent
EXPO
$3.19B
– –
-8,641
Closed -$822K
EXTR icon
505
Extreme Networks
EXTR
$3.8B
– –
-23,026
Closed -$310K
EYPT icon
506
EyePoint Inc
EYPT
$999M
– –
-877,790
Closed -$7.64M
FAST icon
507
Fastenal
FAST
$54.8B
– –
-20,764
Closed -$652K
FERG icon
508
Ferguson
FERG
$43.9B
– –
-4,118
Closed -$797K
FFIC
509
DELISTED
Flushing Financial
FFIC
– –
-66,357
Closed -$873K
FFIV icon
510
F5
FFIV
$22B
– –
-1,720
Closed -$296K
FIS icon
511
Fidelity National Information Services
FIS
$24.2B
– –
-3,417
Closed -$258K
FIZZ icon
512
National Beverage
FIZZ
$3.06B
– –
-6,713
Closed -$344K
FLS icon
513
Flowserve
FLS
$8.94B
– –
-21,812
Closed -$1.05M
FNB icon
514
FNB Corp
FNB
$6.76B
– –
-19,421
Closed -$266K
FR icon
515
First Industrial Realty Trust
FR
$8.66B
– –
-6,152
Closed -$292K
FRT icon
516
Federal Realty Investment Trust
FRT
$10.9B
– –
-2,521
Closed -$255K
FSLY icon
517
Fastly Inc
FSLY
$3.24B
– –
-22,760
Closed -$168K
FTNT icon
518
Fortinet
FTNT
$112B
– –
-6,484
Closed -$391K
FWRD icon
519
Forward Air
FWRD
$461M
– –
-12,703
Closed -$242K
GBDC icon
520
Golub Capital BDC
GBDC
$3.33B
– –
-67,056
Closed -$1.05M
GDRX icon
521
GoodRx Holdings
GDRX
$1.09B
– –
-22,123
Closed -$173K
GILD icon
522
Gilead Sciences
GILD
$165B
– –
-1,491,000
Closed -$102M
GOOGL icon
523
Alphabet (Google) Class A
GOOGL
$4.12T
– –
-1,340
Closed -$244K
HAE icon
524
Haemonetics
HAE
$3.88B
– –
-6,036
Closed -$499K
HAIN icon
525
Hain Celestial
HAIN
$44.6M
– –
-124,589
Closed -$861K
19 20
21
22 23

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2024 Portfolio in Review

As of Q3 2024, Deerfield Management held 678 positions worth $6.69B, up 11% from $6.01B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $395M in Q3 2024, closing 235 positions and reducing 72 holdings. Its most notable exit was Gilead Sciences, an estimated $102M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 83% a quarter earlier, followed by Industrials and Technology.

Against the trend, Deerfield Management opened a new position in Indivior Pharmaceuticals worth $49.7M.

  • Deerfield Management's largest Q3 2024 buy was Indivior Pharmaceuticals: 5,092,642 shares worth $49.7M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2024, an estimated $85.8M increase.
  • Deerfield Management's biggest Q3 2024 reduction was Surgery Partners, cutting an estimated $86.4M.
  • Deerfield Management fully exited Gilead Sciences in Q3 2024, selling an estimated $102M.
  • Deerfield Management's ten largest holdings make up 54% of its $6.69B portfolio in Q3 2024.
  • Deerfield Management opened 246 new positions and closed 235 in Q3 2024.
  • Deerfield Management's portfolio value rose 11% quarter-over-quarter to $6.69B.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.